arrow
E

Eva Hellström-Lindberg

karolinska institutet
H指数:63
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population-based study

合并症和突变,包括单次和多次打击的TET2突变,与慢性骨髓单核细胞白血病预后的关系——一项基于人群的研究

2025-11-250
OAAI
An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndrome

炎症性T细胞-基质轴对人类骨髓增生异常综合征中造血干/祖细胞衰竭和克隆演化的贡献

2025-11-180
OAAI
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia

炎症性基质细胞和T细胞介导克隆性造血和骨髓增生异常综合征中的人类骨髓微环境重塑

2025-11-180
OAAI
DISRUPTED HARMONY: IFN-RESPONSIVE T CELLS AND INFLAMMATORY MSCS RESHAPE THE BONE MARROW NICHE IN CHIP AND MDS THE TITO BASTIANELLO AND MDSF YOUNG INVESTIGATORS AWARDS

失调的和谐:IFN应答性T细胞和炎性MSCs重塑CHIP和MDS中的骨髓微环境——Tito Bastianello和MDSF青年 investigator 奖

2025-09-010
PRE
SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms

SF3B1突变模型揭示了UBA1作为骨髓增生异常性肿瘤的治疗靶点

Leukemia
IF13.4
2025-08-260
OAAI
A Precision Medicine Approach to the Myelodysplastic Syndrome with Isolated Deletion 5q, Fifty Years After Its Discovery

孤立性5q缺失骨髓增生异常综合征的精准医学研究进展——发现五十周年纪念

Blood
IF23.1
2025-08-060
PRE
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery

孤立性5q缺失骨髓增生异常综合征的精准医学研究,自其发现以来的50年

Blood
IF23.1
2025-08-060
PRE
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10)
LEUKEMIA
IF13.4
2024-12-230
OAAI
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

如何管理种系DDX41变异患者: 来自骨髓肿瘤种系易感性北欧工作组的建议

2024-08-130
OAAI
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

del(5q) 骨髓增生异常肿瘤患者停用来那度胺后的输血独立性: HARMONY Alliance研究

LEUKEMIA
IF13.4
2024-08-050
OA
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel
2024-07-190
OAAI
Somatic mutations associate with clonal expansion of CD8+ T cells

体细胞突变与CD8 T细胞的克隆扩增有关

2024-06-071
OAAI
Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
2024-04-230
OAAI
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT
2023-12-017
PRE
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts
2023-11-032
OAAI
Implementation and adoption of a web tool to support precision diagnostic and treatment decisions for patient with myelodysplastic syndromes

实施和采用网络工具以支持骨髓增生异常综合征患者的精确诊断和治疗决策

2023-04-040
PRE